| Company
| Exchange
| Symbol
| Last price
|
| Quote change
| Market cap
|
|
|
Yunnan Green-Land Biological Technology
| SHE
|
002200
|
15.08
|
|
+0.72
(5.01%)
| 2.28B
|
|
|
YUNNAN GREEN-LAND BIOLOGICAL TECHNOLOGY CO., LTD. is a China-based company
engaged in the plantation and sale of greening plants, as well as the designing
...
| |
| |
|
|
Chongqing Zhifei Biological Prdct Co Ltd
| SHE
|
300122
|
41.92
|
|
+0.52
(1.26%)
| 16.77B
|
|
|
Chongqing Zhifei Biological Products Co., Ltd is principally engaged in the
research, development, production and distribution of vaccine products, ...
| |
| |
|
|
Zhejiang Shenghua Biok Biology Co., Ltd
| SHA
|
600226
|
5.83
|
|
+0.08
(1.39%)
| 2.36B
|
|
|
ZHEJIANG SHENGHUA BIOK BIOLOGY CO., LTD. is mainly engaged in the production and
distribution of pesticide and veterinary products.
| |
| |
|
|
Hualan Biological Engineering, Inc.
| SHE
|
002007
|
24.53
|
|
0.00
(0.00%)
| 14.13B
|
|
|
HUALAN BIOLOGICAL ENGINEERING, INC. is principally engaged in the research and
development, production and sale of blood products and vaccine products.
| |
| |
|
|
Beijing Tiantan Biological Products Corp
| SHA
|
600161
|
16.44
|
|
-0.24
(-1.44%)
| 8.47B
|
|
|
Beijing Tiantan Biological Products Corporation Limited is a China-based company
principally engaged in biopharmaceutical industry.
| |
| |
|
|
Baolingbao Biology Co., Ltd.
| SHE
|
002286
|
15.85
|
|
-0.01
(-0.06%)
| 2.93B
|
|
|
BAOLINGBAO BIOLOGY CO., LTD. is principally engaged in the processing,
manufacture and sale of oligosaccharide, high fructose syrup and tetrahydroxy
butane.
| |
| |
|
|
Beihai Gofar Marine Biological Industry
| SHA
|
600538
|
4.67
|
|
-0.02
(-0.43%)
| 1.30B
|
|
|
Beihai Gofar Marine Biological Industry Co., Ltd. is principally engaged in the
manufacture and distribution of agricultural chemical products.
| |
| |
|
|
STERIS Corp
| NYSE
|
STE
|
45.71
|
|
+0.40
(0.88%)
| 2.67B
|
|
|
STERIS Corporation (STERIS) is a provider of infection prevention and surgical
products and services, focused on healthcare, pharmaceutical and research.
| |
| |
|
|
Chesapeake Biological Laboratories, Inc.
| Private
|
|
|
|
|
|
|
|
Chesapeake Biological bays about pharmaceutical prospects. Chesapeake Biological
Laboratories (CBL) provides product development and commercial drug ...
| |
| |
|
|
Biological Signal Processing Ltd.
| TLV
|
BSP
|
23.10
|
|
-0.90
(-3.75%)
| 7.61M
|
|
|
BSP Biological Signal Processing Ltd is an Israel-based company engaged in the
technology sector. The Company offers products for non-invasive diagnosis and
...
| |
| |
|
|
Mesa Laboratories, Inc.
| NASDAQ
|
MLAB
|
52.18
|
|
-0.27
(-0.51%)
| 176.34M
|
|
|
Mesa Laboratories, Inc. (Mesa) manufactures and distributes electronic
measurement systems and disposable products for various niche applications, ...
| |
| |
|
|
Bruker Corporation
| NASDAQ
|
BRKR
|
17.08
|
|
+0.08
(0.50%)
| 2.85B
|
|
|
Bruker Corporation (Bruker) is a global manufacturer of scientific instruments
that address the rapidly evolving needs of a diverse array of customers in ...
| |
| |
|
|
STERIS CORP.
| FRA
|
STQ
|
34.51
|
|
-0.06
(-0.17%)
|
|
|
|
|
|
|
BRUKER CORP. DL -,01
| ETR
|
BKD
|
9.58
|
|
|
|
|
|
|
|
|
BRUKER CORP. DL -,01
| FRA
|
BKD
|
13.10
|
|
+0.06
(0.48%)
|
|
|
|
|
|
|
Thermo Fisher Scientific Inc.
| NYSE
|
TMO
|
86.98
|
|
+1.29
(1.51%)
| 31.22B
|
|
|
In September 2012, Thermo Fisher opened its Molecular Biology Center of
Excellence in Vilnius, Lithuania. In October 2012, OpenGate Capital, LLC
acquired ...
| |
| |
|
|
PerkinElmer, Inc.
| NYSE
|
PKI
|
31.68
|
|
-0.08
(-0.25%)
| 3.55B
|
|
|
PerkinElmer, Inc. is a provider of technology, services and solutions to the
diagnostics, research, environmental, industrial and laboratory services ...
| |
| |
|
|
Qiagen NV
| NASDAQ
|
QGEN
|
19.00
|
|
+0.07
(0.37%)
| 4.45B
|
|
|
Provides genetically oriented technlogy. The Company provides enabling
technologies and products for separating and purifying nucleic acids (DNA and
RNA).
| |
| |
|
|
Qiagen NV
| FRA
|
QIA
|
14.65
|
|
+0.18
(1.24%)
| 3.43B
|
|
|
Provides genetically oriented technlogy. The Company provides enabling
technologies and products for separating and purifying nucleic acids (DNA and
RNA).
| |
| |
|
|
Qiagen NV
| ETR
|
QIA
|
14.66
|
|
+0.16
(1.14%)
| 3.43B
|
|
|
Provides genetically oriented technlogy. The Company provides enabling
technologies and products for separating and purifying nucleic acids (DNA and
RNA).
| |
| |
|
|
Show all 34 companies »
|
|
